Why the study?
Advancements in surgical and transcatheter interventions have improved short-term outcomes for tricuspid regurgitation, but evidence regarding long-term outcomes remains lacking.
What are the long-term outcomes of surgical and transcatheter interventions in patients with tricuspid regurgitation?
What are the long-term outcomes of surgical and transcatheter interventions in patients with tricuspid regurgitation?
This comprehensive review summarizes recent findings on the long-term outcomes of surgical and transcatheter interventions for tricuspid regurgitation to guide clinical decision-making.
Answers are grounded in this paper and cite their sources.
May guide tricuspid regurgitation management; leaves open optimal strategies pending prospective trials.
Impacting more than 70 million people worldwide, tricuspid regurgitation (TR) refers to the retrograde flow of blood from the right ventricle to the right atrium due to the improper closure of the tricuspid valve. Depending on the severity of TR, signs and symptoms can range from asymptomatic to features of right heart failure, including dyspnea, exercise intolerance, peripheral edema, and ascites. Severe features such as these necessitate treatment. In recent years, advancements in management, including surgical and transcatheter interventions, have taken prominence, leading to improved short-term outcomes in this patient population. However, there is still a dearth of evidence regarding the long-term outcomes of surgical and transcatheter interventions for TR. This comprehensive review aims to present clinicians with recent findings from pivotal clinical studies on interventional clinical outcomes in an effort to help guide their judgment when it comes to deciding the best course of treatment for their patients.
No takes yet. Share an insight, caveat, or question.
Tasouli-Drakou et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: